KYUNG NAM PHARM.CO.,LTD. Logo

KYUNG NAM PHARM.CO.,LTD.

South Korean maker of OTC medicines, health foods, and cosmetics, known for its Lemona Vitamin C.

053950 | KO

Overview

Corporate Details

ISIN(s):
KR7053950002
LEI:
Country:
South Korea
Address:
경상남도 의령군 동동리 1539-5, 의령군
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1957, Kyung Nam Pharm Co., Ltd. is a South Korean pharmaceutical company specializing in the manufacturing and sale of over-the-counter (OTC) medicines, health functional foods, and cosmetics. The company is renowned for its flagship brand, Lemona, which was introduced in 1983 as the country's first powdered Vitamin C and has since become a leading product in the vitamin and inner-beauty markets. Its portfolio also includes well-known OTC products such as 'PM' for athlete's foot and 'Minol F Troche' for sore throats. Kyung Nam Pharm is also a prominent manufacturer of human placenta-based medicines, reinforcing its long-standing focus on consumer health and wellness.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-10 00:00
Share Issue/Capital Change
전환가액의조정
Korean 22.8 KB
2025-08-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 87.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-08-11 00:00
Share Issue/Capital Change
전환가액의조정
Korean 22.0 KB
2025-07-10 00:00
Share Issue/Capital Change
전환가액의조정
Korean 21.6 KB
2025-06-27 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 97.1 KB
2025-06-23 00:00
Share Issue/Capital Change
전환가액의조정
Korean 14.4 KB
2025-06-10 00:00
Share Issue/Capital Change
전환가액의조정
Korean 21.1 KB
2025-05-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 87.6 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-05-12 00:00
Share Issue/Capital Change
전환가액의조정
Korean 20.7 KB
2025-04-10 00:00
Share Issue/Capital Change
전환가액의조정
Korean 20.7 KB
2025-03-20 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.9 KB
2025-03-12 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 581.0 KB
2025-03-10 00:00
Share Issue/Capital Change
전환가액의조정
Korean 20.3 KB

Automate Your Workflow. Get a real-time feed of all KYUNG NAM PHARM.CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KYUNG NAM PHARM.CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KYUNG NAM PHARM.CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

KOREA ARLICO PHARM CO.,LTD. Logo
Manufactures generic drugs and provides CDMO services to a global market.
South Korea
260660
Develops and manufactures prescription (ETC) and over-the-counter (OTC) medicines for public health.
South Korea
014570
Korro Bio, Inc. Logo
A clinical-stage biopharma using RNA editing to develop medicines for rare & prevalent diseases.
United States of America
KRRO
K Pharma,Inc. Logo
Develops iPS cell-based drugs and regenerative medicine for central nervous system disorders.
Japan
4896
Kringle Pharma,Inc. Logo
Develops regenerative HGF medicines for rare and intractable neurological diseases.
Japan
4884
Krka Logo
Develops and sells generic prescription, non-prescription, and animal health products globally.
Slovenia
KRKG
Krystal Biotech, Inc. Logo
Developing redosable gene therapies for rare diseases using a modified HSV-1 vector.
United States of America
KRYS
KUKJEON PHARMACEUTICAL Co.,Ltd Logo
A chemical solutions provider manufacturing Active Pharmaceutical Ingredients and electronic materials.
South Korea
307750
Kura Oncology, Inc. Logo
Develops targeted precision medicines for high-need cancers like leukemia, head & neck, and lung cancer.
United States of America
KURA
KWANGDONG PHARMACEUTICAL CO.,LTD Logo
Developing drugs & health goods by integrating oriental and Western medicine.
South Korea
009290

Talk to a Data Expert

Have a question? We'll get back to you promptly.